Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epithelial differentiation and proliferative potential in spinal ependymomas.

Hiroaki Takeuchi1, Toshihiko Kubota, Kazufumi Sato

  • 1Department of Neurosurgery, Fukui Medical University, Yoshida-gun, Japan. takeu@fmsrsa.fukui-med.ac.jp

Journal of Neuro-Oncology
|August 6, 2002
PubMed
Summary

Spinal ependymomas show epithelial differentiation, unlike spinal astrocytomas. Intracranial ependymomas exhibit higher proliferation than spinal ependymomas, suggesting regional differences influence tumor characteristics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combinatorial analysis of clinical and genomic data used to assess the association between SARS-CoV-2 mutations and disease severity.

PNAS nexus·2026
Same author

Current status of eradication therapy and antimicrobial susceptibility testing for Helicobacter pylori in Japan: A nationwide questionnaire survey.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

Attractiveness of Green Stink Bugs <i>Nezara</i> spp. to Ultraviolet-Based Multichromatic Light Traps: Synergistic Effects of Ultraviolet and Blue Light.

Insects·2026
Same author

Bloody diarrhea associated with cytotoxic Aeromonas enteropelogenes harboring act and aerA genes: A case report highlighting diagnostic pitfalls.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

Refractory pneumonia due to persistent SARS-CoV-2 infection in an immunocompromised host successfully treated with extended course nirmatrelvir/ritonavir.

ASM case reports·2025
Same author

Application of HIV-1 viral protein R-derived-peptides as new E3 ligase-binding components of BRD4 degraders.

RSC chemical biology·2025

Area of Science:

  • Neuro-oncology
  • Pathology
  • Cancer Biology

Background:

  • Ependymomas and astrocytomas are primary spinal cord tumors with distinct origins.
  • Understanding epithelial differentiation and proliferative activity is crucial for tumor classification and prognosis.

Purpose of the Study:

  • To compare epithelial differentiation and proliferative activity between spinal ependymomas, spinal astrocytomas, and intracranial ependymomas.
  • To investigate the role of epithelial markers (EMA, cytokeratins) and Ki-67 labeling index in differentiating these tumors.

Main Methods:

  • Histopathological and immunohistochemical analysis of 35 spinal cord tumors (11 ependymomas, 13 astrocytomas) and 11 intracranial ependymomas.
  • Application of epithelial markers: anti-epithelial membrane antigen (EMA) and anti-cytokeratin antibodies (CAM 5.2, keratin).

Related Experiment Videos

  • Assessment of tumor proliferation using the Ki-67 labeling index (LI).

    • Main Results:

    • Spinal ependymomas showed immunoreactivity for EMA (82%) and CAM 5.2 (73%), unlike spinal astrocytomas which were negative for these markers.
    • Spinal astrocytomas showed minimal keratin expression (1/13).
    • The Ki-67 LI was significantly lower in spinal ependymomas compared to intracranial ependymomas (p < 0.01).

    Conclusions:

    • Ependymomas, both spinal and intracranial, exhibit epithelial differentiation, distinguishing them from spinal astrocytomas.
    • Regional differences in ependymomas (spinal vs. intracranial) impact their proliferative activity and potentially other histo-pathological features.
    • These findings highlight distinct biological characteristics influencing tumor behavior and clinical presentation.